DRviaSPCN (Q113676): Difference between revisions
From MaRDI portal
Changed an Item |
Added link to MaRDI item. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI software profile / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 18:55, 12 March 2024
Drug Repurposing in Cancer via a Subpathway Crosstalk Network
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DRviaSPCN |
Drug Repurposing in Cancer via a Subpathway Crosstalk Network |
Statements
13 January 2024
0 references
A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results.
0 references
expanded from: GPL (≥ 2) (English)
0 references
